BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2116698)

  • 1. [The determination of apolipoproteins Apo A-I and Apo B. A comparative study of methods].
    Keller H; Riesen WF
    Z Med Lab Diagn; 1990; 31(4):200-10. PubMed ID: 2116698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative determination of apolipoprotein AI in serum by the use of monoclonal antibodies in a noncompetitive ELISA].
    Winkler L; Müller DW; Dargel R; Jäger L
    Z Med Lab Diagn; 1990; 31(3):159-64. PubMed ID: 2114707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of 6 serum pools in standardization of the determination of apolipoproteins AI and B in the human serum].
    Beucler I; Caces E; Camare R; Dachet C; Fruchart JC; Gambert P; Girault A; Leglise D; Legrand A; Mainard F
    Ann Biol Clin (Paris); 1990; 48(7):443-7. PubMed ID: 2126170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of the immunochemical detection of apolipoprotein A-I and B].
    Dati F; Marcovina SM; Albers JJ
    Behring Inst Mitt; 1990 Oct; (86):116-28. PubMed ID: 2123624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in AI, B and E apolipoproteins induced by infusion of lipid emulsions in critical patients].
    Locati L; Zagara G; Feré A
    Minerva Anestesiol; 1989 Dec; 55(12):505-8. PubMed ID: 2517678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma apolipoproteins AI and B: reference values in the Isère population and determination of individual values].
    Foulon T; Laporte F; Payen N; Groslambert P
    Ann Biol Clin (Paris); 1998; 56(4):451-6. PubMed ID: 9754281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.
    Billingham MS; Milles JJ; Green A; Bailey CJ; Hall RA
    Scand J Clin Lab Invest; 1989 May; 49(3):239-47. PubMed ID: 2500699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia].
    Hachem H; Raynal G; Favre G; Hamza M; Canal P; Soula G
    Ann Biol Clin (Paris); 1985; 43(6):885-90. PubMed ID: 3938627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method.
    Sandkamp M; Tambyrajah B; Schriewer H; Assmann G
    J Clin Chem Clin Biochem; 1988 Nov; 26(11):685-8. PubMed ID: 3148681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of mixed micelles and vesicles of human apolipoproteins A-I and A-II with synthetic and natural lecithins and the bile salt sodium taurocholate: quasi-elastic light scattering studies.
    Donovan JM; Benedek GB; Carey MC
    Biochemistry; 1987 Dec; 26(25):8215-33. PubMed ID: 3126801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen-progestin contraception and biohumoral response of new markers of the atheroma risk. Behavior of lipoprotein(a) and apolipoproteins A and B].
    Porcelli A; Calleri L; Gallello D; Taccani C; Surico N
    Minerva Ginecol; 1997 Mar; 49(3):63-6. PubMed ID: 9173339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.
    Brustolin D; Maierna M; Aguzzi F; Zoppi F; Tarenghi G; Berti G
    Clin Chem; 1991 May; 37(5):742-7. PubMed ID: 1903334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.
    Sniderman AD
    Can J Cardiol; 1988 Jul; 4 Suppl A():24A-30A. PubMed ID: 3141025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum.
    Riepponen P; Marniemi J; Rautaoja T
    Scand J Clin Lab Invest; 1987 Nov; 47(7):739-44. PubMed ID: 3685874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease.
    Koren-Morag N; Goldbourt U; Graff E; Tanne D
    J Neurol Sci; 2008 Jul; 270(1-2):82-7. PubMed ID: 18377938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.